New drug duo aims to shrink tough head and neck cancers
NCT ID NCT03468218
Summary
This study is testing whether a combination of two drugs, pembrolizumab and cabozantinib, can help control advanced head and neck cancer that has come back or spread. The trial will involve about 36 patients whose cancer cannot be removed by surgery. Researchers want to see if this drug pair can shrink tumors and slow the cancer's progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Emory University Hospital Midtown
Atlanta, Georgia, 30308, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.